Protein Homeostasis in Models of Aging and Age-Related Conformational Disease

  • Elise A. Kikis
  • Tali Gidalevitz
  • Richard I. Morimoto

Abstract

The stability of the proteome is crucial to the health of the cell, and contributes significantly to the lifespan of the organism. Aging and many age-related diseases have in common the expression of misfolded and damaged proteins. The chronic expression of damaged proteins during disease can have devastating consequences on protein homeostasis (proteostasis), resulting in disruption of numerous biological processes. This chapter discusses our current understanding of the various contributors to protein misfolding, and the mechanisms by which misfolding, and accompanied aggregation/toxicity, is accelerated by stress and aging. Invertebrate models have been instrumental in studying the processes related to aggregation and toxicity of disease-associated proteins and how dysregulation of proteostasis leads to neurodegenerative diseases of aging.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998; 396:336–342.PubMedCrossRefGoogle Scholar
  2. 2.
    Stevens FJ, Argon Y. Pathogenic light chains and the B-cell repertoire. Immunol Today 1999; 20:451–457.PubMedCrossRefGoogle Scholar
  3. 3.
    Gidalevitz T, Ben-Zvi A, Ho KH et al. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 2006; 311:1471–1474.PubMedCrossRefGoogle Scholar
  4. 4.
    Yeyati PL, Bancewicz RM, Maule J et al. Hsp90 selectively modulates phenotype in vertebrate development. PLoS Genet 2007; 3:e43.PubMedCrossRefGoogle Scholar
  5. 5.
    Michels AA, Kanon B, Konings AW et al. Hsp70 and Hsp40 chaperone activities in the cytoplasm and the nucleus of mammalian cells. J Biol Chem 1997; 272:33283–33289.PubMedCrossRefGoogle Scholar
  6. 6.
    Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 1993; 27:437–496.PubMedCrossRefGoogle Scholar
  7. 7.
    Balch WE, Morimoto RI, Dillin A et al. Adapting proteostasis for disease intervention. Science 2008; 319:916–919.PubMedCrossRefGoogle Scholar
  8. 8.
    Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298–300.PubMedGoogle Scholar
  9. 9.
    Sohal RS, Weindruch R. Oxidative stress, caloric restriction and aging. Science 1996; 273:59–63.PubMedCrossRefGoogle Scholar
  10. 10.
    Berlett BS, Stadtman ER. Protein oxidation in aging, disease and oxidative stress. J Biol Chem 1997; 272:20313–20316.PubMedCrossRefGoogle Scholar
  11. 11.
    Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 1991; 266:2005–2008.PubMedGoogle Scholar
  12. 12.
    Smith CD, Carney JM, Starke-Reed PE et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 1991; 88:10540–10543.PubMedCrossRefGoogle Scholar
  13. 13.
    Stadtman ER. Protein oxidation and aging. Science 1992; 257:1220–1224.PubMedCrossRefGoogle Scholar
  14. 14.
    Ahmed N, Dobler D, Dean M et al. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 2005; 280:5724–5732.PubMedCrossRefGoogle Scholar
  15. 15.
    Lo TW, Westwood ME, McLellan AC et al. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine and N alpha-acetyllysine and bovine serum albumin. J Biol Chem 1994; 269:32299–32305.PubMedGoogle Scholar
  16. 16.
    Kalapos MP. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 1999; 110:145–175.PubMedCrossRefGoogle Scholar
  17. 17.
    Kuhla B, Boeck K, Schmidt A et al. Age-and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer’s disease brains. Neurobiol Aging 2007; 28:29–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Hipkiss AR. On the mechanisms of ageing suppression by dietary restriction-is persistent glycolysis the problem? Mech Ageing Dev 2006; 127:8–15.PubMedCrossRefGoogle Scholar
  19. 19.
    Gnerer JP, Kreber RA, Ganetzky B. Wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration and early death. Proc Natl Acad Sci USA 2006; 103:14987–14993.PubMedCrossRefGoogle Scholar
  20. 20.
    Moskovitz J. Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr Pharm Des 2005; 11:1451–1457.PubMedCrossRefGoogle Scholar
  21. 21.
    Friguet B. Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett 2006; 580:2910–2916.PubMedCrossRefGoogle Scholar
  22. 22.
    Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 1993; 62:797–821.PubMedCrossRefGoogle Scholar
  23. 23.
    Hanson SR, Hasan A, Smith DL et al. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res 2000; 71:195–207.PubMedCrossRefGoogle Scholar
  24. 24.
    Breusing N, Grune T. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 2008; 389:203–209.PubMedCrossRefGoogle Scholar
  25. 25.
    Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001; 83:301–310.PubMedCrossRefGoogle Scholar
  26. 26.
    Shringarpure R, Grune T, Mehlhase J et al. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003; 278:311–318.PubMedCrossRefGoogle Scholar
  27. 27.
    Shang F, Nowell TR Jr, Taylor A. Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp Eye Res 2001; 73:229–238.PubMedCrossRefGoogle Scholar
  28. 28.
    Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 2002; 4:674–680.PubMedCrossRefGoogle Scholar
  29. 29.
    Reinheckel T, Grune T, Davies KJ. The measurement of protein degradation in response to oxidative stress. Methods Mol Biol 2000; 99:49–60.PubMedGoogle Scholar
  30. 30.
    Kiffin R, Christian C, Knecht E et al. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004; 15:4829–4840.PubMedCrossRefGoogle Scholar
  31. 31.
    Schultz SC, Richards JH. Site-saturation studies of beta-lactamase: production and characterization of mutant beta-lactamases with all possible amino acid substitutions at residue 71. Proc Natl Acad Sci USA 1986; 83:1588–1592.PubMedCrossRefGoogle Scholar
  32. 32.
    Pakula AA, Sauer RT. Genetic analysis of protein stability and function. Annu Rev Genet 1989; 23:289–310.PubMedCrossRefGoogle Scholar
  33. 33.
    Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006; 7:61–80.PubMedCrossRefGoogle Scholar
  34. 34.
    DePristo MA, Weinreich DM, Hartl DL. Missense meanderings in sequence space: a biophysical view of protein evolution. Nat Rev Genet 2005; 6:678–687.PubMedCrossRefGoogle Scholar
  35. 35.
    Suckow J, Markiewicz P, Kleina LG et al. Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J Mol Biol 1996; 261:509–523.PubMedCrossRefGoogle Scholar
  36. 36.
    Sachidanandam R, Weissman D, Schmidt SC et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928–933.PubMedCrossRefGoogle Scholar
  37. 37.
    Drummond DA, Wilke CO. Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolution. Cell 2008; 134:341–352.PubMedCrossRefGoogle Scholar
  38. 38.
    Gidalevitz T, Krupinski T, Garcia S et al. Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet 2009; 5:e1000399.PubMedCrossRefGoogle Scholar
  39. 39.
    Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 2003; 81:678–699.PubMedCrossRefGoogle Scholar
  40. 40.
    Kopito RR, Ron D. Conformational disease. Nat Cell Biol 2000; 2:E207–209.PubMedCrossRefGoogle Scholar
  41. 41.
    Lee JW, Beebe K, Nangle LA et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006; 443:50–55.PubMedCrossRefGoogle Scholar
  42. 42.
    Jordanova A, Irobi J, Thomas FP et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006; 38:197–202.PubMedCrossRefGoogle Scholar
  43. 43.
    Martin I, Grotewiel MS. Oxidative damage and age-related functional declines. Mech Ageing Dev 2006; 127:411–423.PubMedGoogle Scholar
  44. 44.
    Calderwood SK, Murshid A, Prince T. The Shock of Aging: Molecular Chaperones and the Heat Shock Response in Longevity and Aging—A Mini-Review. Gerontology 2009.Google Scholar
  45. 45.
    Holmberg CI, Staniszewski KE, Mensah KN et al. Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J 2004; 23:4307–4318.PubMedCrossRefGoogle Scholar
  46. 46.
    Kim S, Nollen EA, Kitagawa K et al. Polyglutamine protein aggregates are dynamic. Nat Cell Biol 2002; 4:826–831.PubMedCrossRefGoogle Scholar
  47. 47.
    Suhr ST, Senut MC, Whitelegge JP et al. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol 2001; 153:283–294.PubMedCrossRefGoogle Scholar
  48. 48.
    Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 2007; 80:727–739.PubMedCrossRefGoogle Scholar
  49. 49.
    Westerheide SD, Morimoto RI. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 2005; 280:33097–33100.PubMedCrossRefGoogle Scholar
  50. 50.
    Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8:519–529.PubMedCrossRefGoogle Scholar
  51. 51.
    Banerji SS, Theodorakis NG, Morimoto RI. Heat shock-induced translational control of HSP70 and globin synthesis in chicken reticulocytes. Mol Cell Biol 1984; 4:2437–2448.PubMedGoogle Scholar
  52. 52.
    Xiao X, Zuo X, Davis AA et al. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J 1999; 18:5943–5952.PubMedCrossRefGoogle Scholar
  53. 53.
    Santos SD, Saraiva MJ. Enlarged ventricles, astrogliosis and neurodegeneration in heat shock factor 1 null mouse brain. Neuroscience 2004; 126:657–663.PubMedCrossRefGoogle Scholar
  54. 54.
    Zhang P, McGrath B, Li S et al. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth and the function and viability of the pancreas. Mol Cell Biol 2002; 22:3864–3874.PubMedCrossRefGoogle Scholar
  55. 55.
    Reimold AM, Iwakoshi NN, Manis J et al. Plasma cell differentiation requires the transcription factor XBP-1. Nature 2001; 412:300–307.PubMedCrossRefGoogle Scholar
  56. 56.
    Zhang K, Wong HN, Song B et al. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B-cell lymphopoiesis. J Clin Invest 2005; 115:268–281.PubMedGoogle Scholar
  57. 57.
    Elefant F, Palter KB. Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality. Mol Biol Cell 1999; 10:2101–2117.PubMedGoogle Scholar
  58. 58.
    Feder JH, Rossi JM, Solomon J et al. The consequences of expressing hsp70 in Drosophila cells at normal temperatures. Genes Dev 1992; 6:1402–1413.PubMedCrossRefGoogle Scholar
  59. 59.
    Nylandsted J, Rohde M, Brand K et al. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000; 97:7871–7876.PubMedCrossRefGoogle Scholar
  60. 60.
    Whitesell L, Mimnaugh EG, De Costa B et al. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 1994; 91:8324–8328.PubMedCrossRefGoogle Scholar
  61. 61.
    Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005; 5:761–772.PubMedCrossRefGoogle Scholar
  62. 62.
    Duyao M, Ambrose C, Myers R et al. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat Genet 1993; 4:387–392.PubMedCrossRefGoogle Scholar
  63. 63.
    Morley JF, Brignull HR, Weyers JJ et al. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci USA 2002; 99:10417–10422.PubMedCrossRefGoogle Scholar
  64. 64.
    Morris JZ, Tissenbaum HA, Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 1996; 382:536–539.bl]ReferencesPubMedCrossRefGoogle Scholar
  65. 65.
    Lin K, Dorman JB, Rodan A et al. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 1997; 278:1319–1322.PubMedCrossRefGoogle Scholar
  66. 66.
    Morley JF, Morimoto RI. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell 2004; 15:657–664.PubMedCrossRefGoogle Scholar
  67. 67.
    Hsu AL, Murphy CT, Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003; 300:1142–1145.PubMedCrossRefGoogle Scholar
  68. 68.
    Cohen E, Bieschke J, Perciavalle RM et al. Opposing activities protect against age-onset proteotoxicity. Science 2006; 313:1604–1610.PubMedCrossRefGoogle Scholar
  69. 69.
    Lithgow GJ, White TM, Melov S et al. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc Natl Acad Sci USA 1995; 92:7540–7544.PubMedCrossRefGoogle Scholar
  70. 70.
    Salmon AB, Sadighi Akha AA, Buffenstein R et al. Fibroblasts from naked mole-rats are resistant to multiple forms of cell injury, but sensitive to peroxide, ultraviolet light and endoplasmic reticulum stress. J Gerontol A Biol Sci Med Sci 2008; 63:232–241.PubMedGoogle Scholar
  71. 71.
    Salmon AB, Murakami S, Bartke A et al. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Am J Physiol Endocrinol Metab 2005; 289:E23–29.PubMedCrossRefGoogle Scholar
  72. 72.
    Broughton SJ, Piper MD, Ikeya T et al. Longer lifespan, altered metabolism and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc Natl Acad Sci USA 2005; 102:3105–3110.PubMedCrossRefGoogle Scholar
  73. 73.
    Tullet JM, Hertweck M, An JH et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 2008; 132:1025–1038.PubMedCrossRefGoogle Scholar
  74. 74.
    Prahlad V, Cornelius T, Morimoto RI. Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons. Science 2008; 320:811–814.PubMedCrossRefGoogle Scholar
  75. 75.
    Bienz M. Developmental control of the heat shock response in Xenopus. Proc Natl Acad Sci USA 1984; 81:3138–3142.PubMedCrossRefGoogle Scholar
  76. 76.
    Sprang GK, Brown IR. Selective induction of a heat shock gene in fibre tracts and cerebellar neurons of the rabbit brain detected by in situ hybridization. Brain Res 1987; 427:89–93.PubMedGoogle Scholar
  77. 77.
    Shamovsky I, Gershon D. Novel regulatory factors of HSF-1 activation: facts and perspectives regarding their involvement in the age-associated attenuation of the heat shock response. Mech Ageing Dev 2004; 125:767–775.PubMedCrossRefGoogle Scholar
  78. 78.
    Mathur SK, Sistonen L, Brown IR et al. Deficient induction of human hsp70 heat shock gene transcription in Y79 retinoblastoma cells despite activation of heat shock factor 1. Proc Natl Acad Sci USA 1994; 91:8695–8699.PubMedCrossRefGoogle Scholar
  79. 79.
    Marcuccilli CJ, Mathur SK, Morimoto RI et al. Regulatory differences in the stress response of hippocampal neurons and glial cells after heat shock. J Neurosci 1996; 16:478–485.PubMedGoogle Scholar
  80. 80.
    Batulan Z, Shinder GA, Minotti S et al. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J Neurosci 2003; 23:5789–5798.PubMedGoogle Scholar
  81. 81.
    Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005; 6:11–22.PubMedCrossRefGoogle Scholar
  82. 82.
    Walker GA, Lithgow GJ. Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals. Aging Cell 2003; 2:131–139.PubMedCrossRefGoogle Scholar
  83. 83.
    YYokoyama K, Fukumoto K, Murakami T et al. Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot-2 (mortalin)/mthsp70/Grp75. FEBS Lett 2002; 516:53–57.CrossRefGoogle Scholar
  84. 84.
    Herndon LA, Schmeissner PJ, Dudaronek JM et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 2002; 419:808–814.PubMedCrossRefGoogle Scholar
  85. 85.
    Yang J, Tower J. Expression of hsp22 and hsp70 transgenes is partially predictive of drosophila survival under normal and stress conditions. J Gerontol A Biol Sci Med Sci 2009; 64:828–838.PubMedGoogle Scholar
  86. 86.
    Yun C, Stanhill A, Yang Y et al. Proteasomal adaptation to environmental stress links resistance to proteotoxicity with longevity in Caenorhabditis elegans. Proc Natl Acad Sci USA 2008; 105:7094–7099.PubMedCrossRefGoogle Scholar
  87. 87.
    Brunet A, Sweeney LB, Sturgill JF et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303:2011–2015.PubMedCrossRefGoogle Scholar
  88. 88.
    Westerheide SD, Anckar J, Stevens SM et al. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009; 323:1063–1066.PubMedCrossRefGoogle Scholar
  89. 89.
    Lee SS, Kennedy S, Tolonen AC et al. DAF-16 target genes that control C. elegans life-span and metabolism. Science 2003; 300:644–647.PubMedCrossRefGoogle Scholar
  90. 90.
    Kakizuka A. Protein precipitation: a common etiology in neurodegenerative disorders? Trends Genet 1998; 14:396–402.PubMedCrossRefGoogle Scholar
  91. 91.
    Chiti F, Dobson CM. Protein misfolding, functional amyloid and human disease. Annu Rev Biochem 2006; 75:333–366.PubMedCrossRefGoogle Scholar
  92. 92.
    Warrick JM, Paulson HL, Gray-Board GL et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 1998; 93:939–949.PubMedCrossRefGoogle Scholar
  93. 93.
    Faber PW, Alter JR, MacDonald ME et al. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci USA 1999; 96:179–184.PubMedCrossRefGoogle Scholar
  94. 94.
    Feany MB, Bender WW. A Drosophila model of Parkinson’s disease. Nature 2000; 404:394–398.PubMedCrossRefGoogle Scholar
  95. 95.
    Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 2000; 97:1589–1594.PubMedCrossRefGoogle Scholar
  96. 96.
    Satyal SH, Schmidt E, Kitagawa K et al. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci USA 2000; 97:5750–5755.PubMedCrossRefGoogle Scholar
  97. 97.
    Parker JA, Connolly JB, Wellington C et al. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci USA 2001; 98:13318–13323.PubMedCrossRefGoogle Scholar
  98. 98.
    Warrick JM, Chan HY, Gray-Board GL et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 1999; 23:425–428.PubMedCrossRefGoogle Scholar
  99. 99.
    Kazemi-Esfarjani P, Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 2000; 287:1837–1840.PubMedCrossRefGoogle Scholar
  100. 100.
    Nollen EA, Garcia SM, van Haaften G et al. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci USA 2004; 101:6403–6408.PubMedCrossRefGoogle Scholar
  101. 101.
    Garcia SM, Casanueva MO, Silva MC et al. Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans postsynaptic muscle cells. Genes Dev 2007; 21:3006–3016.PubMedCrossRefGoogle Scholar
  102. 102.
    Jackson GR, Salecker I, Dong X et al. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 1998; 21:633–642.PubMedCrossRefGoogle Scholar
  103. 103.
    Brignull HR, Moore FE, Tang SJ et al. Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci 2006; 26:7597–7606.PubMedCrossRefGoogle Scholar
  104. 104.
    Marsh JL, Walker H, Theisen H et al. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum Mol Genet 2000; 9:13–25.PubMedCrossRefGoogle Scholar
  105. 105.
    Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 1995; 92:9368–9372.PubMedCrossRefGoogle Scholar
  106. 106.
    Finelli A, Kelkar A, Song HJ et al. A model for studying Alzheimer’s Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci 2004; 26:365–375.PubMedCrossRefGoogle Scholar
  107. 107.
    Wittmann CW, Wszolek MF, Shulman JM et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001; 293:711–714.PubMedCrossRefGoogle Scholar
  108. 108.
    Kraemer BC, Zhang B, Leverenz JB et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci USA 2003; 100:9980–9985.PubMedCrossRefGoogle Scholar
  109. 109.
    Nussbaum RL, Polymeropoulos MH. Genetics of Parkinson’s disease. Hum Mol Genet 1997; 6:1687–1691.PubMedCrossRefGoogle Scholar
  110. 110.
    Chase TN. A gene for Parkinson disease. Arch Neurol 1997; 54:1156–1157.PubMedGoogle Scholar
  111. 111.
    Lakso M, Vartiainen S, Moilanen AM et al. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem 2003; 86:165–172.PubMedCrossRefGoogle Scholar
  112. 112.
    van Ham TJ, Thijssen KL, Breitling R et al. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 2008; 4:e1000027.PubMedCrossRefGoogle Scholar
  113. 113.
    Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 364:362.PubMedGoogle Scholar
  114. 114.
    Watson MR, Lagow RD, Xu K et al. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem 2008; 283:24972–24981.PubMedCrossRefGoogle Scholar
  115. 115.
    Wang J, Farr GW, Hall DH et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet 2009; 5:e1000350.PubMedCrossRefGoogle Scholar
  116. 116.
    Ahn SG, Thiele DJ. Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev 2003; 17:516–528.PubMedCrossRefGoogle Scholar
  117. 117.
    Hahn JS, Thiele DJ. Activation of the Saccharomyces cerevisiae heat shock transcription factor under glucose starvation conditions by Snf1 protein kinase. J Biol Chem 2004; 279:5169–5176.PubMedCrossRefGoogle Scholar
  118. 118.
    Thomson S, Hollis A, Hazzalin CA et al. Distinct stimulus-specific histone modifications at hsp70 chromatin targeted by the transcription factor heat shock factor-1. Mol Cell 2004; 15:585–594.PubMedCrossRefGoogle Scholar
  119. 119.
    Ananthan J, Goldberg AL, Voellmy R. Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science 1986; 232:522–524.PubMedCrossRefGoogle Scholar
  120. 120.
    Hiromi Y, Okamoto H, Gehring WJ et al. Germline transformation with Drosophila mutant actin genes induces constitutive expression of heat shock genes. Cell 1986; 44:293–301.PubMedCrossRefGoogle Scholar
  121. 121.
    Parsell DA, Sauer RT. Induction of a heat shock-like response by unfolded protein in Escherichia coli: dependence on protein level not protein degradation. Genes Dev 1989; 3:1226–1232.PubMedCrossRefGoogle Scholar
  122. 122.
    Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1988; 22:631–677.PubMedCrossRefGoogle Scholar
  123. 123.
    Morimoto RI. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones and negative regulators. Genes Dev 1998; 12:3788–3796.PubMedCrossRefGoogle Scholar
  124. 124.
    Morimoto RI, Kline MP, Bimston DN et al. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 1997; 32:17–29.PubMedGoogle Scholar
  125. 125.
    Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996; 381:571–579.PubMedCrossRefGoogle Scholar
  126. 126.
    Bukau B, Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell 1998; 92:351–366.PubMedCrossRefGoogle Scholar
  127. 127.
    Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003; 228:111–133.Google Scholar
  128. 128.
    Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006; 125:443–451.PubMedCrossRefGoogle Scholar
  129. 129.
    Kieran D, Kalmar B, Dick JR et al. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 2004; 10:402–405.PubMedCrossRefGoogle Scholar
  130. 130.
    Katayama T, Imaizumi K, Honda A et al. Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer’s disease-linked presenilin-1 mutations. J Biol Chem 2001; 276:43446–43454.PubMedCrossRefGoogle Scholar
  131. 131.
    Cowan KJ, Diamond MI, Welch WJ. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum Mol Genet 2003; 12:1377–1391.PubMedCrossRefGoogle Scholar
  132. 132.
    Hay DG, Sathasivam K, Tobaben S et al. Progressive decrease in chaperone protein levels in a mouse model of Huntington’s disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 2004; 13:1389–1405.PubMedCrossRefGoogle Scholar
  133. 133.
    Zourlidou A, Gidalevitz T, Kristiansen M et al. Hsp27 overexpression in the R6/2 mouse model of Huntington’s disease: chronic neurodegeneration does not induce Hsp27 activation. Hum Mol Genet 2007; 16:1078–1090.PubMedCrossRefGoogle Scholar
  134. 134.
    Wen FC, Li YH, Tsai HF et al. Down-regulation of heat shock protein 27 in neuronal cells and nonneuronal cells expressing mutant ataxin-3. FEBS Lett 2003; 546:307–314.PubMedCrossRefGoogle Scholar
  135. 135.
    Chai Y, Koppenhafer SL, Bonini NM et al. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci 1999; 19:10338–10347.PubMedGoogle Scholar
  136. 136.
    Stenoien DL, Cummings CJ, Adams HP et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1 and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 1999; 8:731–741.PubMedCrossRefGoogle Scholar
  137. 137.
    Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001; 292:1552–1555.PubMedCrossRefGoogle Scholar
  138. 138.
    Nishitoh H, Matsuzawa A, Tobiume K et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002; 16:1345–1355.PubMedCrossRefGoogle Scholar
  139. 139.
    Tatzelt J, Zuo J, Voellmy R et al. Scrapie prions selectively modify the stress response in neuroblastoma cells. Proc Natl Acad Sci USA 1995; 92:2944–2948.PubMedCrossRefGoogle Scholar
  140. 140.
    Van Dyk TK, Gatenby AA, LaRossa RA. Demonstration by genetic suppression of interaction of GroE products with many proteins. Nature 1989; 342:451–453.PubMedCrossRefGoogle Scholar
  141. 141.
    Brown CR, Hong-Brown LQ, Welch WJ. Correcting temperature-sensitive protein folding defects. J Clin Invest 1997; 99:1432–1444.PubMedCrossRefGoogle Scholar
  142. 142.
    Bilen J, Bonini NM. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 2007; 3:1950–1964.PubMedCrossRefGoogle Scholar
  143. 143.
    Ben-Zvi A, Miller EA, Morimoto RI. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci USA 2009.Google Scholar
  144. 144.
    Fraser AG, Kamath RS, Zipperlen P et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 2000; 408:325–330.PubMedCrossRefGoogle Scholar
  145. 145.
    Kamath RS, Martinez-Campos M, Zipperlen P et al. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol 2001; 2:RESEARCH0002.PubMedGoogle Scholar
  146. 146.
    Ghosh S, Feany MB. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases. Hum Mol Genet 2004; 13:2011–2018.PubMedCrossRefGoogle Scholar
  147. 147.
    Kitamura A, Kubota H, Pack CG et al. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol 2006; 8:1163–1170.PubMedCrossRefGoogle Scholar
  148. 148.
    Behrends C, Langer CA, Boteva R et al. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol Cell 2006; 23:887–897.PubMedCrossRefGoogle Scholar
  149. 149.
    Tam S, Geller R, Spiess C et al. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol 2006; 8:1155–1162.PubMedCrossRefGoogle Scholar
  150. 150.
    Kraemer BC, Burgess JK, Chen JH et al. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet 2006; 15:1483–1496.PubMedCrossRefGoogle Scholar
  151. 151.
    Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001; 24:1121–1159.PubMedCrossRefGoogle Scholar
  152. 152.
    Shulman JM, Feany MB. Genetic modifiers of tauopathy in Drosophila. Genetics 2003; 165:1233–1242.PubMedGoogle Scholar
  153. 153.
    Auluck PK, Chan HY, Trojanowski JQ et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 2002; 295:865–868.PubMedCrossRefGoogle Scholar
  154. 154.
    Lamitina T, Huang CG, Strange K. Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc Natl Acad Sci USA 2006; 103:12173–12178.PubMedCrossRefGoogle Scholar
  155. 155.
    Willingham S, Outeiro TF, DeVit MJ et al. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 2003; 302:1769–1772.PubMedCrossRefGoogle Scholar
  156. 156.
    Faber PW, Voisine C, King DC et al. Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc Natl Acad Sci USA 2002; 99:17131–17136.PubMedCrossRefGoogle Scholar
  157. 157.
    Powers ET, Morimoto RI, Dillin A et al. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 2009; 78:959–991.PubMedCrossRefGoogle Scholar
  158. 158.
    Westerheide SD, Kawahara TL, Orton K et al. Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 2006; 281:9616–9622.PubMedCrossRefGoogle Scholar
  159. 159.
    Mathew A, Mathur SK, Morimoto RI. Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway. Mol Cell Biol 1998; 18:5091–5098.PubMedGoogle Scholar
  160. 160.
    Rossi A, Elia G, Santoro MG. Activation of the heat shock factor 1 by serine protease inhibitors. An effect associated with nuclear factor-kappaB inhibition. J Biol Chem 1998; 273:16446–16452.PubMedCrossRefGoogle Scholar
  161. 161.
    Bagatell R, Paine-Murrieta GD, Taylor CW et al. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. Clin Cancer Res 2000; 6:3312–3318.PubMedGoogle Scholar
  162. 162.
    Bagatell R, Whitesell L. Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 2004; 3:1021–1030.PubMedCrossRefGoogle Scholar
  163. 163.
    Jurivich DA, Sistonen L, Kroes RA et al. Effect of sodium salicylate on the human heat shock response. Science 1992; 255:1243–1245.PubMedCrossRefGoogle Scholar
  164. 164.
    Lee BS, Chen J, Angelidis C et al. Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stress-induced cellular damage. Proc Natl Acad Sci USA 1995; 92:7207–7211.PubMedCrossRefGoogle Scholar
  165. 165.
    Amici C, Sistonen L, Santoro MG et al. Antiproliferative prostaglandins activate heat shock transcription factor. Proc Natl Acad Sci USA 1992; 89:6227–6231.PubMedCrossRefGoogle Scholar
  166. 166.
    Jurivich DA, Sistonen L, Sarge KD et al. Arachidonate is a potent modulator of human heat shock gene transcription. Proc Natl Acad Sci USA 1994; 91:2280–2284.PubMedCrossRefGoogle Scholar
  167. 167.
    Westerheide SD, Bosman JD, Mbadugha BN et al. Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 2004; 279:56053–56060.PubMedCrossRefGoogle Scholar
  168. 168.
    Trott A, West JD, Klaic L et al. Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol Biol Cell. 2008;19(3):1104–12. Epub 2008 Jan 16.PubMedCrossRefGoogle Scholar
  169. 169.
    Katsuno M, Sang C, Adachi H et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci USA 2005; 102:16801–16806.PubMedCrossRefGoogle Scholar
  170. 170.
    Zhang YQ, Sarge KD. Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response. J Mol Med 2007; 85:1421–1428.PubMedCrossRefGoogle Scholar
  171. 171.
    Boyce M, Bryant KF, Jousse C et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005; 307:935–939.PubMedCrossRefGoogle Scholar
  172. 172.
    Parker JA, Arango M, Abderrahmane S et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005; 37:349–350.PubMedCrossRefGoogle Scholar
  173. 173.
    Voisine C, Varma H, Walker N et al. Identification of potential therapeutic drugs for huntington’s disease using Caenorhabditis elegans. PLoS ONE 2007; 2:e504.PubMedCrossRefGoogle Scholar
  174. 174.
    Varma H, Cheng R, Voisine C et al. Inhibitors of metabolism rescue cell death in Huntington’s disease models. Proc Natl Acad Sci USA 2007; 104:14525–14530.PubMedCrossRefGoogle Scholar
  175. 175.
    Varma H, Voisine C, DeMarco CT et al. Selective inhibitors of death in mutant huntingtin cells. Nat Chem Biol 2007; 3:99–100.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Elise A. Kikis
    • 1
  • Tali Gidalevitz
    • 1
  • Richard I. Morimoto
    • 1
  1. 1.Department of Biochemistry, Molecular Biology and Cell Biology, Rice Institute for Biomedical ResearchNorthwestern UniversityEvanstonUSA

Personalised recommendations